Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
6.25
+0.30 (5.04%)
Apr 1, 2026, 1:22 PM EDT - Market open
Zura Bio Employees
Zura Bio had 30 employees as of December 31, 2024. The number of employees increased by 15 or 100.00% compared to the previous year.
Employees
30
Change (1Y)
15
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$3,311,767
Market Cap
593.00M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 30 | 15 | 100.00% | 30 | 0 |
| Dec 31, 2023 | 15 | - | - | 14 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Valneva SE | 674 |
| CorMedix | 191 |
| Allogene Therapeutics | 152 |
| Prime Medicine | 146 |
| Alpha Tau Medical | 121 |
| Zevra Therapeutics | 61 |
| Tectonic Therapeutic | 60 |
ZURA News
- 12 days ago - Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates - Business Wire
- 27 days ago - Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress - Business Wire
- 4 weeks ago - Zura Bio to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Business Wire
- 5 weeks ago - Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants - Business Wire
- 5 weeks ago - Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants - Business Wire
- 5 weeks ago - Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D. - Business Wire
- 2 months ago - Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit - Business Wire